Rodríguez AAM, Cuellar PJC, Abilio LCS

Language: Spanish
References: 10
Page: 151-153
PDF size: 243.20 Kb.

Text Extraction

To the Editor:

Nosocomial pneumonia (NP) are those that appear 48 hours after hospital admission, and they are the second leading cause of infection in general wards and the first cause in intensive care units (ICUs) worldwide. Its incidence has been reported between 10-20%, which can reach up to 20% in patients receiving artificial mechanical ventilation, and its mortality exceeds 50%1-3; that is why they are considered diseases of high morbidity, mortality and socio-economic impact.

REFERENCES

1. Cabrera RA, Laguna HG, Villagómez OAJ, Méndez RR, Guzmán GR. Neumonía adquirida en hospitales. Un problema común que merece mayor atención. Med Int Mex. 2009;25:31-7.

2. Jordà Marcos R, Torres Martí A, Ariza Cardenal FJ, Álvarez Lerma F, Barcenilla Gaite F, Comisión de Expertos del Grupo de Trabajo de Enfermedades Infecciosas de la Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias (GTEISEMICYUC), Área de Trabajo de Tuberculosis e Infecciones Respiratorias de la Sociedad Española de Patología del Aparato Respiratorio (TIR-SEPAR) y Grupo de Estudio de Infección Hospitalaria de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (GEIH-SEIMC). Recomendaciones para el tratamiento de la neumonía intrahospitalaria grave. Enferm Infecc Micro-biol Clin. 2004; 22:471-85.

3. Mangino JE, Peyrani P, Ford KD, Kett DH, Zervos MJ, Welch VL, et al. Development and implementation of a performance improvement project in adult intensive care units: overview of the Improving Medicine Through Pathway Assessment of Critical Therapy in Hospital-Ac-quired Pneumonia (IMPACT-HAP) study. Crit Care [Internet]. 2011 [ci-tado 23 Oct 2014]; 15:R38. Disponible en: http://www.ncbi.nlm.nih.go v/pmc/articles/PMC3222076/p df/cc9988.pdf

4. Höffken G, Niederman MS. Nosocomial pneumonia: the importance of a deescalating strategy for antibiotic treatment of pneumonia in the ICU. Chest. 2002;122:2183-96.

5. Niederman MS, Soulountsi V. De-escalation therapy: is it valuable for the management of ventilatorassociated pneumonia? Clin Chest Med. 2011;32: 517-34.

6. Apisarnthanarak, A. Bhooanusas, N. Yaprasert, A. Carbapenem de-escalation therapy in a resourcelimited setting. Infect Control Hosp Epidemiol. 2013;34:1310-3.

7. Dünser MW, Festic E, Dondorp A, Kissoon N, Ganbat T, Kwizera A, et al. Recommendations for sepsis management in resource-limited settings. Intensive Care Med. 2012;38:557-74.

8. Maldonado-Ortiz A, Niederman MS, Arancibia HF, Osorio J, Regalado PJ, Sereno B, et al. Informe de la conferencia de Consenso Interamericana sobre Neumonía Nosocomial y Asociada a la Ventilación Mecánica. Rev Inst Nal Enf Resp Mex. 2005;18:298- 307.

9. Escudero D, Blanco A, Quindós B. Terapia secuencial con medicamentos. Conversión de la vía intravenosa a la vía oral. ¿Una buena estrategia para disminuir la bacteriemia relacionada con catéter?. Med Intensiva. 2014;38:99-103.

10. Johanson WG, Pierce AK, Sanford JP, Thomas GD. Nosocomial respiratory infections with Gram negative bacilli. The significance of colonization of the respiratory tract. Ann Intern Med. 1972;77:701-6.